0001209191-18-036187.txt : 20180606 0001209191-18-036187.hdr.sgml : 20180606 20180606201253 ACCESSION NUMBER: 0001209191-18-036187 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180604 FILED AS OF DATE: 20180606 DATE AS OF CHANGE: 20180606 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Danziger Asaf CENTRAL INDEX KEY: 0001654435 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37565 FILM NUMBER: 18885008 MAIL ADDRESS: STREET 1: 5 NACHUM CHAT ST. CITY: TIRAT HACARMEL STATE: L3 ZIP: 5112302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NovoCure Ltd CENTRAL INDEX KEY: 0001645113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF BUSINESS PHONE: 44 (0)15 3475 6700 MAIL ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF FORMER COMPANY: FORMER CONFORMED NAME: Novocure Ltd DATE OF NAME CHANGE: 20150615 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-06-04 0 0001645113 NovoCure Ltd NVCR 0001654435 Danziger Asaf C/O NOVOCURE INC. 20 VALLEY STREAM PARKWAY, SUITE 300 MALVERN PA 19355 1 1 0 0 Chief Executive Officer Ordinary Shares 2018-06-04 4 S 0 149878 28.43 D 260246 D Ordinary Shares 2018-06-04 4 S 0 26782 29.31 D 233464 D Ordinary Shares 2018-06-04 4 S 0 28150 30.34 D 205314 D Ordinary Shares 2018-06-04 4 S 0 19694 31.64 D 185620 D Ordinary Shares 2018-06-04 4 S 0 2800 32.00 D 182820 D On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 149,878 shares in multiple trades at prices ranging from $28.00 to $28.95. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 26,782 shares in multiple trades at prices ranging from $29.00 to $29.95. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 28,150 shares in multiple trades at prices ranging from $30.00 to $30.95. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 19,694 shares in multiple trades at prices ranging from $31.00 to $31.975. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger. By: /s/ Kimberly Burke, Attorney in fact for Asaf Danziger 2018-06-06